Inventor · disambiguated record
Suguna Rachakonda
Also filed as: RACHAKONDA SUGUNA · RACHAKONDA SUGUNA H
16 granted patents·7 pending applications·654 citations·filing 2005–2024
95Inventor score
Top patents by PatentIndex Score
23 records- 0198US8642756B2Nucleoside phosphoramidatesROSS BRUCE·Filed 2010·Granted Feb 4, 2014·89 cites·23 claims
- 0297US9284342B2Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2013·Granted Mar 15, 2016·23 cites·9 claims
- 0397US8633309B2Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2013·Granted Jan 21, 2014·44 cites·12 claims
- 0497US8629263B2Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2013·Granted Jan 14, 2014·62 cites·25 claims
- 0597US8618076B2Nucleoside phosphoramidatesROSS BRUCE S·Filed 2011·Granted Dec 31, 2013·102 cites·36 claims
- 0696US8735569B2Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2013·Granted May 27, 2014·48 cites·6 claims
- 0796US8716263B2Synthesis of purine nucleosidesCHUN BYOUNG-KWON·Filed 2009·Granted May 6, 2014·73 cites·24 claims
- 0896US8492539B2Preparation of 2′-fluoro-2′-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivativesCHUN BYOUNG-KWON·Filed 2005·Granted Jul 23, 2013·52 cites·7 claims
- 0995US8859756B2Stereoselective synthesis of phosphorus containing activesROSS BRUCE S·Filed 2011·Granted Oct 14, 2014·61 cites·16 claims
- 1094US9045520B2Synthesis of purine nucleosidesCHUN BYOUNG-KWON·Filed 2012·Granted Jun 2, 2015·46 cites·4 claims
- 1193US9206217B2Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2013·Granted Dec 8, 2015·16 cites·4 claims
- 1288US9637512B2Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2014·Granted May 2, 2017·3 cites·5 claims
- 1388US8912321B2Preparation of nucleosides ribofuranosyl pyrimidinesAXT STEVEN D·Filed 2007·Granted Dec 16, 2014·34 cites·7 claims
- 1483US2025057867A1Nucleoside phosphoramidatesGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1577US10577359B2Preparation of 2′-fluoro-2′-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivativesGILEAD PHARMASSET LLC·Filed 2017·Granted Mar 3, 2020·1 cites·2 claims
- 1672US12116350B2Compounds for treating ILK-mediated diseasesCLEVELAND CLINIC FOUND·Filed 2022·Granted Oct 15, 2024·0 cites·11 claims
- 1768US2018044367A1Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2017·Application pending·0 cites
- 1862US2016354400A1Nucleoside phosphoramidatesGILEAD PHARMASSET LLC·Filed 2016·Application pending·0 cites
- 1961US11524945B2Compounds for treating ILK-mediated diseasesCLEVELAND CLINIC FOUND·Filed 2019·Granted Dec 13, 2022·0 cites·20 claims
- 2059US2013338349A1Preparation of 2'-fluoro-2'-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivativesGILEAD PHARMASSET LLC·Filed 2013·Application pending·0 cites
- 2157US2008139802A1Preparation of nucleosides ribofuranosyl pyrimidinesROCHE PALO ALTO LLC·Filed 2007·Application pending·0 cites
- 2252US2016024061A1Preparation of 2'-fluoro-2'-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivativesGILEAD PHARMASSET LLC·Filed 2015·Application pending·0 cites
- 2351US2009099136A1Dioxolane thymine phosphoramidates as anti-hiv agentsPHARMASSET INC·Filed 2008·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →